Scopio Labs, a leading provider of Full Field Morphology (FFM), announced today that it was granted FDA clearance to market and sell its X100 with Full Field Peripheral Blood Smear (Full Field PBS) Application, unlocking the potential of in vitro hematology diagnosis. Full Field PBS is also available in Europe with CE mark certification granted earlier this year.
Read more here.
![[Beyond Meat in CNBC] If you invested $1,000 in Beyond Meat at IPO, here’s how much you’d have now](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
